Recombinant Human VCAM-1

Vascular cell adhesion molecule 1, also known as VCAM1 is an immunoglobulin-like adhesion molecule expressed on activated endothelial cells.¹ This type I membrane protein mediates leukocyte-endothelial cell adhesion and signal transduction, and may play a role in the development of artherosclerosis and rheumatoid arthritis. VCAM-1 promotes the adhesion of lymphocytes, monocytes, eosinophils, and basophils.

The biological activity of Human VCAM-1 was determined by its ability to support adhesion of U937 human histiocytic lymphoma cells.

mfkiett pesrylaqig dsvsltcstt gcespffswr tqidsplngk vtnegttstl tmnpvsfgne hsylctatce srklekgiqv eiysfpkdpe ihlsgpleag kpitvkcsva dvypfdrlei dllkgdhlmk sqefledadr ksletkslev tftpviedig kvlvcraklh idemdsvptv rqavkelqvy ispkntvisv npstklqegg svtmtcsseg lpapeifwsk kldngnlqhl sgnatltlia mrmedsgiyv cegvnligkn rkevelivqe kpftveispg priaaqigds vmltcsvmgc espsfswrtq idsplsgkvr segtnstltl spvsfenehs ylctvtcghk klekgiqvel ysfprdpeie msgglvngss vtvsckvpsv ypldrleiel lkgetileni efledtdmks lenkslemtf iptiedtgka lvcqaklhid dmefepkqrq stqtlyvnva prdttvlvsp ssileegssv nmtclsqgfp apkilwsrql pngelqplse natltlistk medsgvylce ginqagrsrk eveliiqvtp kdikltafps esvkegdtvi isctcgnvpe twiilkkkae tgdtvlksid gaytirkaql kdagvyeces knkvgsqlrs ltldvqgren nkdyfspe

Lyophilized

The predicted molecular weight of Recombinant Human VCAM-1 is Mr 74 kDa. However, the actual molecular weight as observed by migration onSDS-PAGE is Mr 90-95 kDa.

74

This recombinant protein was 0.2 µm filtered and lyophilized from modified Dulbecco’s phosphate buffered saline (1X PBS) pH 7.2 – 7.3 with no calcium, magnesium, or preservatives

This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution, this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.

Next Day Ambient

1. Huo, Y. et al. (2001) J Clin Invest 107: 1209